CASTNC Annual Meeting

What: CASTNC Annual Meeting

When: Saturday, Nov 16, 2013, 3:00-6:00pm

Where: NCSU, SAS Hall, Room 2203         (2311 Stinson Dr., Raleigh, NC 27607)

Map & Direction:: http://goo.gl/maps/xwJ1v

Notes: Free admission. Drinks and snacks will be provided.

 

Featured Speaker 1: 金飞鸿, 北京金房有限公司董事长,中国保险公司海外投资项目高级顾问讲演题目:现阶段中国海外投资的机遇及挑战---实例介绍

 

Featured Speaker 2:   Qingyi Wei, M.Sc, M.D., Ph.D.

Topic:  Molecular Epidemiology of Lung Cancer

Dr. Wei is Associate Director for Cancer Control and Population Sciences, Co-Leader of Duke’s Cancer Prevention, Detection and Control Program at Duke Cancer Institute, Duke University Medical Center. He is also Professor of Medicine, Department of Medicine, Duke University School of Medicine.

A native of Nanjin, Dr. Wei was trained as a physician in public health at Nanjing Medical College with a diploma in Preventive Medicine between 1978 and 1983. After graduation from Nanjing Medical College, he enrolled in a master training program in 1983 and earned his master degree in Environmental Toxicology at Chinese Academy of Preventive Medicine in Beijing, China in 1987. Then, he came to USA and enrolled in a doctoral training program in epidemiology at Johns Hopkins University School of Hygiene and Public Health and obtained his PhD degree in epidemiology in 1993, where he had also been trained as a post-doctoral fellow in molecular epidemiology in 1993 in the Department of Biochemistry.

He joined The University of Texas M.D. Anderson Cancer Center in Houston, Texas, as a tenure-track Assistant Professor of Epidemiology and Assistant Epidemiologist in July, 1993 and was later promoted to Associate Professor in 1998, Full Professor in 2003, and The Texas 4000 Endowed Distinguished Professor in 2011. He research goals have been to develop a battery of biomarkers for assessing cancer susceptibility with an emphasis on DNA repair and apoptosis as well as to use these biomarkers in molecular epidemiological studies aimed at identifying susceptible or at-risk individuals. In the past twenty years, as one of few molecular epidemiologists in this nation, he has established himself as one of leading investigators in molecular epidemiology of cancers with an expertise in using DNA repair and apoptosis as biomarkers for investigating genetic susceptibility to cancers. In September, 2013, he was recruited by Duke Cancer Institute as Associate Direct for Cancer Control and Population Sciences at Duke University Medical Center.

 

Please sign up the CASTNC Annual Meeting below: